Cancer Research SABCS  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krop, I.
Right arrow Articles by Polyak, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krop, I.
Right arrow Articles by Polyak, K.
[Cancer Research 65, 11326-11334, December 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

A Putative Role for Psoriasin in Breast Tumor Progression

Ian Krop1,3, Annette März7, Hanna Carlsson8, Xiaochun Li2,4, Noga Bloushtain-Qimron1, Min Hu1,3, Rebecca Gelman2,4, Michael S. Sabel9, Stuart Schnitt5, Sridhar Ramaswamy3,6, Celina G. Kleer10, Charlotta Enerbäck8 and Kornelia Polyak1,3

Departments of 1 Medical Oncology and 2 Biostatistical Science, Dana-Farber Cancer Institute; 3 Department of Medicine, Harvard Medical School; 4 Harvard School of Public Health; and 5 Department of Pathology, Beth Israel Deaconess Medical Center; 6 Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts; 7 Department of Tumor Virology, Heinrich-Pette-Institute, Hamburg, Germany; 8 Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden; and Departments of 9 Surgery and 10 Pathology, University of Michigan Cancer Center, Ann Arbor, Michigan

Requests for reprints: Kornelia Polyak, Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street D740C, Boston, MA 02115. Phone: 617-632-2106; Fax: 617-632-4005; E-mail: Kornelia_Polyak{at}dfci.harvard.edu.

Psoriasin (S100A7) was identifi`ed as a gene highly expressed in psoriatic keratinocytes and highly and more frequently expressed in ductal carcinoma in situ (DCIS) than in invasive breast carcinomas (IBC), suggesting a potential role in tumor progression. Psoriasin expression is associated with poor prognostic factors in both DCIS and IBC. Several putative functions have been proposed for psoriasin in various disease types, but none of these can fully explain its involvement in breast tumor progression. Here, we show that down-regulation of endogenous psoriasin expression via stable short hairpin RNAs in a human IBC cell line (MDA-MB-468) increases cell migration and invasion without influencing cell proliferation and survival in vitro but inhibits tumor growth in vivo. These seemingly paradoxical results are potentially explained by the dramatic up-regulation and down-regulation of matrix metalloproteinase-13 and vascular endothelial growth factor (VEGF), respectively, observed in cells with decreased psoriasin levels compared with controls. Correlating with this, high psoriasin expression in human IBC is associated with increased angiogenesis and worse clinical outcome, and psoriasin mRNA levels are coordinately regulated with VEGF and other genes related to hypoxia and mitochondrial reactive oxygen species (ROS). Based on these results, we propose that psoriasin may play a role in breast tumor progression by promoting angiogenesis and enhancing the selection for cells that overcome its anti-invasive function. This hypothesis may explain why psoriasin expression is highest in high-grade and/or estrogen receptor–negative tumors, as these are associated with increased hypoxia and ROS, a setting in which the angiogenic effects of psoriasin are most important. (Cancer Res 2005; 65(24): 11326-34)




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
L Oslejskova, M Grigorian, S Gay, M Neidhart, and L Senolt
The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts
Ann Rheum Dis, November 1, 2008; 67(11): 1499 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu
Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H Zhang, Q Zhao, Y Chen, Y Wang, S Gao, Y Mao, M Li, A Peng, D He, and X Xiao
Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas
Thorax, April 1, 2008; 63(4): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. P.C. Wong, P. Ng, S. Dedhar, and G. Li
The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth
Mol. Cancer Ther., June 1, 2007; 6(6): 1692 - 1700.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.